Amphastar Pharmaceuticals, Inc.
AMPH
$17.50
-$0.95-5.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.52% | -4.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.52% | -4.55% | |||
| Cost of Revenue | 3.50% | 4.55% | |||
| Gross Profit | -17.92% | -13.15% | |||
| SG&A Expenses | 11.98% | -4.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.81% | 2.84% | |||
| Operating Income | -61.72% | -26.46% | |||
| Income Before Tax | -68.50% | 48.35% | |||
| Income Tax Expenses | -51.48% | 79.80% | |||
| Earnings from Continuing Operations | -73.72% | 40.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -73.72% | 40.80% | |||
| EBIT | -61.72% | -26.46% | |||
| EBITDA | -43.98% | -20.15% | |||
| EPS Basic | -73.37% | 42.54% | |||
| Normalized Basic EPS | -68.10% | -27.58% | |||
| EPS Diluted | -72.55% | 37.86% | |||
| Normalized Diluted EPS | -68.03% | -27.68% | |||
| Average Basic Shares Outstanding | -1.27% | -1.22% | |||
| Average Diluted Shares Outstanding | -1.50% | -1.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||